T3	Citation 235 236	7
T1	Context 123 238	These tumors have a prevalence of approximately 7-14% and a have a poor prognosis compared to luminal A tumors [7].
T2	MISQUOTE 1986 2289	Clinically, the majority of claudin-low tumors are poor prognosis estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and epidermal growth factor receptor 2 (HER2)-negative (triple negative) invasive ductal carcinomas with a high frequency of metaplastic and medullary differentiation.
